Lacosamide Solution
Product Images NDC 0121-1012

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 0121-1012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Laco-structure (Lacosamide Oral Solution Cv 1)

FDA Label Image

Laco-fig-1 (Lacosamide Oral Solution Cv 2)

FDA Label Image

Laco-fig-2 (Lacosamide Oral Solution Cv 3)

Laco-fig-2 (Lacosamide Oral Solution Cv 3)
This appears to be a figure with a chart showing the proportion of patients by responder rate for LACOSAMIDE and Placebo groups in various studies. The chart displays the categories Responder Rate (equal to or greater), Improvement, and Worsening. The figure is labeled as Figure 2. Without further context, it is difficult to provide a more specific description of the data presented.*
FDA Label Image

Pai Logo (Lacosamide Oral Solution Cv 4)

Pai Logo (Lacosamide Oral Solution Cv 4)
Pharmaceutical Associates, Inc. is a company based in Greenville, SC 29605 with a website at www.paipharma.com.*
FDA Label Image

Pai Logo (Lacosamide Oral Solution Cv 5)

Pai Logo (Lacosamide Oral Solution Cv 5)
Pharmaceutical Associates, Inc. is a company based in Greenville, SC 29605. Their website is www.paipharma.com.*
FDA Label Image

5 mL (Lacosamide Oral Solution Cv 6)

5 mL (Lacosamide Oral Solution Cv 6)
This is a package of oral solution with 50 mg per 5 mL of dosage. It is not child-resistant, and can only be obtained with a prescription. The package includes an insert. The manufacturer of this product is Pharmaceutica Azzpciotes, Inc. The lot number is 0992050722 and this package can be used until the expiration date of 07/25/2022.*
FDA Label Image

10 mL (Lacosamide Oral Solution Cv 7)

10 mL (Lacosamide Oral Solution Cv 7)
This is a description of Lacosamide, an Oral Solution medication with a strength of 100 mg per 10 mL, manufactured by Pharmaceutics Associates, Inc. in Greenville, SC. The package is not child-resistant and is for RX use only. The Lot number is lot1 with an expiration date of 07/25/2022.*
FDA Label Image

15 mL (Lacosamide Oral Solution Cv 8)

15 mL (Lacosamide Oral Solution Cv 8)
This is a medication packaged by Harmonized Dgpcites Inc., with an NDC code of 0121-2976-15. The medication is oral and contains 150 mg of an unknown substance per milliliter. The package is not child-resistant, and should be opened following the directions provided in the insert. The lot number of this package is lot1, and it has an expiration date of 07/25/2022.*
FDA Label Image

20 mL (Lacosamide Oral Solution Cv 9)

20 mL (Lacosamide Oral Solution Cv 9)
This is a medicine named Lacosamide C, Oral Solution USP, with a strength of 200 mg/20 mL. It comes in a package that is not child-resistant, and it is only available with a prescription. The product is made by a company named Rhamaieugedgggeinnen ne, and this specific package was produced on August 22, 2020, with a lot number of lot1 and an expiration date of July 25, 2022.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.